NeutroGen Mentioned in HealthCapital Berlin Brandenburg Feature

NeutroGen Therapeutics has been featured by HealthCapital Berlin Brandenburg in a company portrait highlighting the startup's mission to improve the treatment of critical neutropenia through a novel neutrophil transfusion therapy.

The article outlines NeutroGen's approach to restoring immune competence in patients experiencing severe neutropenia, a condition commonly associated with cancer treatments, and discusses the company's recent financing, development plans, and growth in Berlin's biotech ecosystem.

Read the full feature here: https://www.healthcapital.de/news/artikel/im-portrait-neutrogen-therapeutics-will-die-behandlung-von-kritischen-neutropenien-verbessern/